Ohcanbohtosat - Mark Krailo

Aiddostahte ozu
  1. 1
    Childhood cancer patients' access to cooperative group cancer programs

    Childhood cancer patients' access to cooperative group cancer programs Dahkki Lihua Liu, Mark Krailo, Gregory H. Reaman, Leslie Bernstein

    Almmustuhtton 2003
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group

    Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group Dahkki Maura O’Leary, Mark Krailo, James R. Anderson, Gregory H. Reaman

    Almmustuhtton 2008
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Infrequent Tumor Initiative of the Children's Oncology Group: Initial Lessons Learned and Their Impact on Future Plans

    Infrequent Tumor Initiative of the Children's Oncology Group: Initial Lessons Learned and Their Impact on Future Plans Dahkki Alberto S. Pappo, Mark Krailo, Zhengjia Chen, Carlos Rodríguez‐Galindo, Gregory H. Reaman

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States)

    An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States) Dahkki Xiao Ou Shu, Mark E. Nesbit, Jonathan D. Buckley, Mark Krailo, Leslie L. Robison

    Almmustuhtton 1995
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Do regular ovulatory cycles increase breast cancer risk?

    Do regular ovulatory cycles increase breast cancer risk? Dahkki Brian E. Henderson, Ronald K. Ross, Howard L. Judd, Mark Krailo, Malcolm C. Pike

    Almmustuhtton 1985
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431

    Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431 Dahkki Etan Orgel, Doojduen Villaluna, Mark Krailo, Adam J. Esbenshade, Lillian Sung, David R. Freyer

    Almmustuhtton 2022
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Carboplatin in childhood brain tumors: A children's cancer study group phase II trial

    Carboplatin in childhood brain tumors: A children's cancer study group phase II trial Dahkki Paul S. Gaynon, Lawrence J. Ettinger, Edward S. Baum, Stuart E. Siegel, Mark Krailo, G. Denman Hammond

    Almmustuhtton 1990
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Predictive power of pretreatment prognostic factors in children with hepatoblastoma: A report from the Children's Oncology Group

    Predictive power of pretreatment prognostic factors in children with hepatoblastoma: A report from the Children's Oncology Group Dahkki Rebecka L. Meyers, Jon R. Rowland, Mark Krailo, Zhengjia Chen, Howard M. Katzenstein, Marcio H. Malogolowkin

    Almmustuhtton 2009
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Treatment of pulmonary metastases of initial stage. I. Hepatoblastoma in childhood. Report from the childrens cancer group

    Treatment of pulmonary metastases of initial stage. I. Hepatoblastoma in childhood. Report from the childrens cancer group Dahkki James H. Feusner, Mark Krailo, Joel E. Haas, John Campbell, David A. Lloyd, Arthur R. Ablin

    Almmustuhtton 1993
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Rare Tumors in Children: Progress Through Collaboration

    Rare Tumors in Children: Progress Through Collaboration Dahkki Alberto S. Pappo, Wayne L. Furman, Kris Ann P. Schultz, Andrea Ferrari, Lee J. Helman, Mark Krailo

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Phase I Trial of Oral Fenretinide in Children With High-Risk Solid Tumors: A Report From the Children's Oncology Group (CCG 09709)

    Phase I Trial of Oral Fenretinide in Children With High-Risk Solid Tumors: A Report From the Children's Oncology Group (CCG 09709) Dahkki Judith G. Villablanca, Mark Krailo, Matthew M. Ames, Joel M. Reid, Gregory H. Reaman, C. Patrick Reynolds

    Almmustuhtton 2006
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial

    Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial Dahkki Adam Levy, Mark Krailo, Susan Chi, Doojduen Villaluna, Linda Springer, Chris Williams‐Hughes, Maryam Fouladi, Amar Gajjar

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group

    Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group Dahkki AeRang Kim, Brigitte C. Widemann, Mark Krailo, Nalini Jayaprakash, Elizabeth Fox, Brenda J. Weigel, Susan M. Blaney

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Redefining the Role of Doxorubicin for the Treatment of Children With Hepatoblastoma

    Redefining the Role of Doxorubicin for the Treatment of Children With Hepatoblastoma Dahkki Marcio H. Malogolowkin, Howard M. Katzenstein, Mark Krailo, Zhengjia Chen, John J. Quinn, Marleta Reynolds, Jorge A. Ortega

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms’ tumor: a Children’s Cancer Group report

    Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms’ tumor: a Children’s Cancer Group report Dahkki Amal Abu‐Ghosh, Mark Krailo, Sven Goldman, Rebecca Slack, Virginia Davenport, Erin Morris, Joseph Laver, Gregory H. Reaman, Mitchell S. Cairo

    Almmustuhtton 2002
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Complete Surgical Resection Is Curative for Children With Hepatoblastoma With Pure Fetal Histology: A Report From the Children's Oncology Group

    Complete Surgical Resection Is Curative for Children With Hepatoblastoma With Pure Fetal Histology: A Report From the Children's Oncology Group Dahkki Marcio H. Malogolowkin, Howard M. Katzenstein, Rebecka L. Meyers, Mark Krailo, Jon M. Rowland, Joel E. Haas, Milton J. Finegold

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children’s Oncology Group ARAR0331 Study

    Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children’s Oncology Group ARAR0331 Study Dahkki Carlos Rodríguez‐Galindo, Mark Krailo, Matthew J. Krasin, Li Huang, M. Beth McCarville, John Hicks, Farzana Pashankar, Alberto S. Pappo

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Phase II study of intermediate‐dose cytarabine in patients with relapsed or refractory Ewing sarcoma: A report from the Children's Oncology Group

    Phase II study of intermediate‐dose cytarabine in patients with relapsed or refractory Ewing sarcoma: A report from the Children's Oncology Group Dahkki Steven G. DuBois, Mark Krailo, Stephen L. Lessnick, Richard A. Smith, Zhengjia Chen, Neyssa Marina, Holcombe E. Grier, Kimberly Stegmaier

    Almmustuhtton 2008
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study

    A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study Dahkki Murali Chintagumpala, Sandrah P. Eckel, Mark Krailo, Michael J. Morris, Adekunle M. Adesina, Roger J. Packer, Ching C. Lau, Amar Gajjar

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Phase I Trial and Pharmacokinetics of Gemcitabine in Children With Advanced Solid Tumors

    Phase I Trial and Pharmacokinetics of Gemcitabine in Children With Advanced Solid Tumors Dahkki Joel M. Reid, Wenchun Qu, Stephanie L. Safgren, Matthew M. Ames, Mark Krailo, Nita L. Seibel, John F. Kuttesch, John S. Holcenberg

    Almmustuhtton 2004
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: